Provided by Tiger Trade Technology Pte. Ltd.

AdvisorShares Dorsey Wright ADR ETF

85.17
+0.72500.86%
Post-market: 85.04-0.1272-0.15%16:10 EDT
Volume:935
Turnover:79.84K
Market Cap:39.60M
PE:- -
High:86.27
Open:86.27
Low:85.04
Close:84.44
52wk High:98.38
52wk Low:77.69
Shares:465.00K
Float Shares:465.00K
Volume Ratio:0.38
T/O Rate:0.20%
Dividend:0.70
Dividend Rate:0.82%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Mizuho Securities Remains a Buy on Belite Bio, Inc. ADR (BLTE)

TIPRANKS
·
Aug 14

Anheuser-Busch InBev S.A. ADR Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 14

Ascentage Pharma Corrects Timing for August 19, 2026 Interim Results Webcast

TIPRANKS
·
Aug 13

Copel Board Approves R$706 Million Interest on Equity and 2025 Form 20-F Filing

TIPRANKS
·
Aug 13

Asian Companies Raise $28 Billion via ADRs in 2024, Marking a Six-Year High, as AI Boom and Valuation Gaps Drive Listings

Stock News
·
Aug 13

Anheuser-Busch InBev S.A. ADR Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 13

New York Closing Stocks

Dow Jones
·
Aug 13

Stocks Ex-Dividend August 14

Dow Jones
·
Aug 13

Haleon’s New Gum‑Health Toothpaste Trial: What Investors Should Watch

TIPRANKS
·
Aug 13

Cantor Fitzgerald Reaffirms Their Buy Rating on Belite Bio, Inc. ADR (BLTE)

TIPRANKS
·
Aug 12

Kaspi.kz Posts Strong H1 2026 Revenue Growth as Costs Hold Profit Flat

TIPRANKS
·
Aug 12

Yi Chen Raises Approval Odds and Lifts Tinlarebant-Focused 12‑Month Price Target to $214 While Reiterating Buy Rating

TIPRANKS
·
Aug 12

NYSE Net Change Percentage Gainers & Losers

Dow Jones
·
Aug 12

NYSE Most Active Issues

Dow Jones
·
Aug 12

Anheuser-Busch InBev S.A. ADR Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 12

Belite Bio Wins FDA Priority Review for Tinlarebant in Stargardt Disease

TIPRANKS
·
Aug 12

Cboe data shows mixed options sentiment in SK Hynix Inc – ADR with shares up 3.07%

TIPRANKS
·
Aug 12

Copel Board Approves Q2 2026 Results and BNDES-Backed R$4 Billion Financing Plan

TIPRANKS
·
Aug 12

Incannex Secures A$5.1M R&D Tax Incentive Refund

TIPRANKS
·
Aug 11

Yimutian Inc. Sets August 31, 2026 Date for Annual General Meeting

TIPRANKS
·
Aug 11